Pt. No. . | Pl factor . | Pathological stage . | Microscopically complete resection . | Adjuvant chemotherapy . | Follow-up period (months) . | Survival . |
---|---|---|---|---|---|---|
1 | 3 | IIB | No | Yes | 5 | Dead |
2 | 3 | IIB | No | No | 6 | Dead |
3 | 1 | IIA | Yes | Yes | 26 | Dead |
4 | 1 | IIA | Yes | Yes | 24 | Alive |
5 | 2 | IB | Yes | No | 27 | Alive |
6 | 1 | IB | Yes | Yes | 28 | Alive |
7 | 2 | IB | Yes | No | 28 | Alive |
8 | 1 | IB | Yes | No | 34 | Alive |
9 | 1 | IB | Yes | No | 52 | Alive |
10 | 0 | IIIA | Yes | Yes | 99 | Alive |
11 | 3 | IIIA | Yes | Yes | 35 | Dead |
12 | 2 | IB | Yes | Yes | 3 | Dead |
13 | 0 | IB | Yes | Yes | 66 | Alive |
14 | 3 | IIA | Yes | No | 6 | Dead |
15 | 3 | IIIA | Yes | No | 33 | Dead |
16 | 3 | IIIA | Yes | No | 1 | Dead |
17 | 1 | IB | Yes | No | 15 | Alive |
18 | 3 | IIB | No | No | 15 | Alive |
19 | 2 | IB | Yes | No | 14 | Alive |
20 | 0 | IIA | Yes | No | 9 | Alive |
21 | 3 | IIB | Yes | No | 56 | Alive |
22 | 3 | IIB | Yes | Yes | 31 | Alive |
23 | 0 | IA | Yes | No | 15 | Alive |
24 | 3 | IIIA | Yes | No | 16 | Alive |
25 | 1 | IB | Yes | No | 21 | Alive |
26 | 0 | IA | Yes | No | 1 | Alive |
Pt. No. . | Pl factor . | Pathological stage . | Microscopically complete resection . | Adjuvant chemotherapy . | Follow-up period (months) . | Survival . |
---|---|---|---|---|---|---|
1 | 3 | IIB | No | Yes | 5 | Dead |
2 | 3 | IIB | No | No | 6 | Dead |
3 | 1 | IIA | Yes | Yes | 26 | Dead |
4 | 1 | IIA | Yes | Yes | 24 | Alive |
5 | 2 | IB | Yes | No | 27 | Alive |
6 | 1 | IB | Yes | Yes | 28 | Alive |
7 | 2 | IB | Yes | No | 28 | Alive |
8 | 1 | IB | Yes | No | 34 | Alive |
9 | 1 | IB | Yes | No | 52 | Alive |
10 | 0 | IIIA | Yes | Yes | 99 | Alive |
11 | 3 | IIIA | Yes | Yes | 35 | Dead |
12 | 2 | IB | Yes | Yes | 3 | Dead |
13 | 0 | IB | Yes | Yes | 66 | Alive |
14 | 3 | IIA | Yes | No | 6 | Dead |
15 | 3 | IIIA | Yes | No | 33 | Dead |
16 | 3 | IIIA | Yes | No | 1 | Dead |
17 | 1 | IB | Yes | No | 15 | Alive |
18 | 3 | IIB | No | No | 15 | Alive |
19 | 2 | IB | Yes | No | 14 | Alive |
20 | 0 | IIA | Yes | No | 9 | Alive |
21 | 3 | IIB | Yes | No | 56 | Alive |
22 | 3 | IIB | Yes | Yes | 31 | Alive |
23 | 0 | IA | Yes | No | 15 | Alive |
24 | 3 | IIIA | Yes | No | 16 | Alive |
25 | 1 | IB | Yes | No | 21 | Alive |
26 | 0 | IA | Yes | No | 1 | Alive |
Pt. No. . | Pl factor . | Pathological stage . | Microscopically complete resection . | Adjuvant chemotherapy . | Follow-up period (months) . | Survival . |
---|---|---|---|---|---|---|
1 | 3 | IIB | No | Yes | 5 | Dead |
2 | 3 | IIB | No | No | 6 | Dead |
3 | 1 | IIA | Yes | Yes | 26 | Dead |
4 | 1 | IIA | Yes | Yes | 24 | Alive |
5 | 2 | IB | Yes | No | 27 | Alive |
6 | 1 | IB | Yes | Yes | 28 | Alive |
7 | 2 | IB | Yes | No | 28 | Alive |
8 | 1 | IB | Yes | No | 34 | Alive |
9 | 1 | IB | Yes | No | 52 | Alive |
10 | 0 | IIIA | Yes | Yes | 99 | Alive |
11 | 3 | IIIA | Yes | Yes | 35 | Dead |
12 | 2 | IB | Yes | Yes | 3 | Dead |
13 | 0 | IB | Yes | Yes | 66 | Alive |
14 | 3 | IIA | Yes | No | 6 | Dead |
15 | 3 | IIIA | Yes | No | 33 | Dead |
16 | 3 | IIIA | Yes | No | 1 | Dead |
17 | 1 | IB | Yes | No | 15 | Alive |
18 | 3 | IIB | No | No | 15 | Alive |
19 | 2 | IB | Yes | No | 14 | Alive |
20 | 0 | IIA | Yes | No | 9 | Alive |
21 | 3 | IIB | Yes | No | 56 | Alive |
22 | 3 | IIB | Yes | Yes | 31 | Alive |
23 | 0 | IA | Yes | No | 15 | Alive |
24 | 3 | IIIA | Yes | No | 16 | Alive |
25 | 1 | IB | Yes | No | 21 | Alive |
26 | 0 | IA | Yes | No | 1 | Alive |
Pt. No. . | Pl factor . | Pathological stage . | Microscopically complete resection . | Adjuvant chemotherapy . | Follow-up period (months) . | Survival . |
---|---|---|---|---|---|---|
1 | 3 | IIB | No | Yes | 5 | Dead |
2 | 3 | IIB | No | No | 6 | Dead |
3 | 1 | IIA | Yes | Yes | 26 | Dead |
4 | 1 | IIA | Yes | Yes | 24 | Alive |
5 | 2 | IB | Yes | No | 27 | Alive |
6 | 1 | IB | Yes | Yes | 28 | Alive |
7 | 2 | IB | Yes | No | 28 | Alive |
8 | 1 | IB | Yes | No | 34 | Alive |
9 | 1 | IB | Yes | No | 52 | Alive |
10 | 0 | IIIA | Yes | Yes | 99 | Alive |
11 | 3 | IIIA | Yes | Yes | 35 | Dead |
12 | 2 | IB | Yes | Yes | 3 | Dead |
13 | 0 | IB | Yes | Yes | 66 | Alive |
14 | 3 | IIA | Yes | No | 6 | Dead |
15 | 3 | IIIA | Yes | No | 33 | Dead |
16 | 3 | IIIA | Yes | No | 1 | Dead |
17 | 1 | IB | Yes | No | 15 | Alive |
18 | 3 | IIB | No | No | 15 | Alive |
19 | 2 | IB | Yes | No | 14 | Alive |
20 | 0 | IIA | Yes | No | 9 | Alive |
21 | 3 | IIB | Yes | No | 56 | Alive |
22 | 3 | IIB | Yes | Yes | 31 | Alive |
23 | 0 | IA | Yes | No | 15 | Alive |
24 | 3 | IIIA | Yes | No | 16 | Alive |
25 | 1 | IB | Yes | No | 21 | Alive |
26 | 0 | IA | Yes | No | 1 | Alive |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.